Angiology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/ang

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilkay, E.
Right arrow Articles by Arslan, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilkay, E.
Right arrow Articles by Arslan, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Angiology, Vol. 57, No. 5, 577-584 (2006)
DOI: 10.1177/0003319706293120

Oral Mycophenolate Mofetil Prevents In-Stent Intimal Hyperplasia Without Edge Effect

Erdogan Ilkay, MD

Cardiology, Firat University Medical School, Elazig, Turkey, ilkayerdogan{at}superonline.com

Latif Tirikli, MD

Cardiology, Firat University Medical School, Elazig, Turkey

Ibrahim Ozercan, MD

Pathology, Firat University Medical School, Elazig, Turkey

Mustafa Yavuzkir, MD

Cardiology, Firat University Medical School, Elazig, Turkey

Ilgin Karaca, MD

Cardiology, Firat University Medical School, Elazig, Turkey

Ali Rahman, MD

Cardiovascular Surgery, Firat University Medical School, Elazig, Turkey

Nadi Arslan, MD

Cardiology, Firat University Medical School, Elazig, Turkey

Neointimal hyperplasia is in the forefront in in-stent restenosis. Prevention of in-stent restenosis is possible by reducing and inhibiting the hyperplasia of smooth muscle cells. The authors planned this study to test the hypothesis that when administered orally, mycophenolate mofetil (MMF) could inhibit in-stent neointimal hyperplasia. The study included 14 New Zealand rabbits. The rabbits were allocated to 2 different groups: Group 1 included 7 rabbits that were given MMF, 40 mg/kg/day by oral route. Group 2 included 7 rabbits that were not given MMF after the stenting. Sampling materials were taken before and after stenting by incising the artery so as to cover a 5-mm area. The samples taken from the edge of the stent in Group 1 showed focal neointimal cell proliferation, but it was less than that from the control group. Neointimal thickness was 0.048 ±0.009 mm and neointimal area was 0.0925 ±0.019 mm2. Apparent neointimal cell proliferation and thickening of the intimal layer were observed in Group 2. Neointimal thickness at the stent edge was 0.147 ±0.051 mm and the neointimal area was 0.154 ±0.023 mm2. The differences between groups in terms of neointimal thickness and neointimal area were statistically significant (p=0.001 for thickness and p=0.001 for area). In-stent artery samples of Group 1 showed that some subjects had no neointimal cell proliferation, while others had very limited focal intimal thickening. Neointimal thickening was 0.071 ±0.003 mm and neointimal area was 0.073 ±0.003 mm2. In Group 2 apparent, and mostly focal, neointimal cell proliferation and formation of intimal layer were observed in the stent. Neointimal thickening was 0.154 ±0.069 mm and neointimal area was 0.279 ±0.059 mm2. The comparison between groups showed significant differences (p=0.011 for thickness and p=0.001 for area). It was established in the third month that endothelialization was completed in both groups. Oral MMF decreased in-stent intimal hyperplasia without edge effect. It was concluded that for the prevention of in-stent restenosis, studies should be conducted for using systemic immunosuppressive treatments in humans as well.

References

  • Sigwart U, Puel J, Mirkovitch V, et al: Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316: 701-706, 1987.[Abstract]
  • Serruys PW, de Jaegere P, Kiemeneij F, et al: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331: 489-495, 1994.[Abstract/Free Full Text]
  • Fischman DL, Leon MB, Baim D, et al: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331: 496-501, 1994.[Abstract/Free Full Text]
  • Serruys PW, de Bruyne B, Carlier S, et al: Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Circulation 102: 2930-2937, 2000.[Abstract/Free Full Text]
  • Dussaillant GR, Mintz GS, Pichard AD, et al: Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis. J Am Coll Cardiol 26: 720-724, 1995.[Abstract]
  • Hoffmann R, Mintz GS, Dussaillant GR, et al: Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 94: 1247-1254, 1996.[Abstract/Free Full Text]
  • Schwartz RS: Animal models of human coronary restenosis. In: Textbook of Interventional Cardiology, ed. 2, ed. by Topol EJ. Philadelphia: WB Saunders, 1994, pp 365-381.
  • Moreno PR, Palacios IF, Leon MN, et al: Histopatho-logic comparison of human coronary in stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 84: 462-466, 1999.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Mach F: Toward new therapeutic strategies against neointimal formation in restenosis. Atheroscler Thromb Vasc Biol 20: 1699-1700, 2000.[Free Full Text]
  • Mudra H, Regar E, Clauss V, et al: Serial follow-up after optimized ultrasound guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. Circulation 95: 363-370, 1997.[Abstract/Free Full Text]
  • Grewe PH, Deneke T, Machraoui A, et al: Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Cardiol 35: 157-163, 1999.
  • Virmani R, Farb A: Pathology of in stent restenosis. Curr Opin Lipidol 10: 499-506, 1999.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Mehran R, Dangas G, Abizaid AS, et al: Angiographic patterns of in-stent restenosis: Classification and implantations for long-term outcome. Circulation 100: 1872-1878, 1999.[Abstract/Free Full Text]
  • Suzuki T, Kopia G, Hayashi S, et al: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104: 1188-1193, 2001.[Abstract/Free Full Text]
  • Sousa JE, Costa MA, Abizaid A, et al: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103: 192-195, 2001.[Abstract/Free Full Text]
  • Sousa JE, Morice MC, Serruys PW, et al: The RAVEL study: A randomized study with sirolimus coated BX velocity balloon-expandable stents in the treatment of patients with de-novo native coronary artery lesions. Circulation 104(suppl II): II-463-II-463, 2001.
  • Morice MC, Serruys PW, Sousa JE, et al: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346: 1773-1780, 2002.[Abstract/Free Full Text]
  • Farb A, Heller PF, Shroff S, et al: Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104: 473-479, 2001.[Abstract/Free Full Text]
  • Allison AC, Eugui EM: Mycophenolate mofetil, a rationally designed immunosuppressive drug. Clin Transpl 7: 96-112, 1993.
  • Franklin TJ, Cook JM: The inhibition of nucleic acid synthesis by mychophenolic acid. Biochem J 113: 515-524, 1969.[ISI][Medline] [Order article via Infotrieve]
  • Kimball J, Pescovitz MD, Book BK, et al: Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil. Transplantation 60: 1379-1383, 1995.[ISI][Medline] [Order article via Infotrieve]
  • Chen C, Mattear SG, Lumbsden AB: Oral administration of L-arginine reduces intimal hyperplasia in balloon injured rat carotid arteries. J Surg Res 82: 17-23, 1999.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Farb A, Tang AL, Shroff S, et al: Neointimal responses 3 months after (32)P b-emitting stent placement. Int J Radiat Oncol Biol Phys 48: 889-898, 2000.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • New G, Moses JW, Roubin SG, et al: Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Cathet Cardiovasc Intervent 57: 266-271, 2002.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Holmes DR Jr, Vlietstra RE, Smith HC, et al: Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 53(suppl): 77C-81C, 1984.[CrossRef][Medline] [Order article via Infotrieve]
  • de Feyter PJ, Vos J, Rensing BJ: Anti-restenosis trials. Curr Intervent Cardiol Rep 2: 326-331, 2000.[Medline] [Order article via Infotrieve]
  • Kastrati A, Schomig A, Dirschinger J, et al: Increased risk of restenosis after placement of gold-coated stents: Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 101: 2478-2483, 2000.[Abstract/Free Full Text]
  • Kuntz RE, Safian RD, Levin MJ, et al: Novel approach to the analysis of restenosis after the use of three new coronary devices. J Am Coll Cardiol 19: 1493-1499, 1992.[Abstract]
  • Mehran R, Dangas G, Mintz GS, et al: Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: Comparative mechanisms and results. Circulation 101: 2484-2489, 2000.[Abstract/Free Full Text]
  • Karaca I, Ilkay E, Akbulut M, et al: Treatment of instent restenosis with excimer-laser coronary angioplasty. Jpn Heart J 44: 179-186, 2003.[CrossRef][Medline] [Order article via Infotrieve]
  • Topol EJ, Leya F, Pinkerton CA, et al: A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med 329: 221-227, 1993.[Abstract/Free Full Text]
  • Baim DS, Cutlip DE, Sharma SK, et al: Final results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 97: 322-331, 1998.[Abstract/Free Full Text]
  • Mudra H, di Mario C, de Jaegere P, et al: Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 104: 1343-1349, 2001.[Abstract/Free Full Text]
  • Teirstein PS, Massullo V, Jani S, et al: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336: 1697-1703, 1997.[Abstract/Free Full Text]
  • Sabate M, Costa MA, Kozuma K, et al: Geographic miss: A cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 21: 2467-2471, 2000.
  • Serruys PW, Kay IP: I like the candy, I hate the wrapper. Circulation 101: 3-7, 2000.[Free Full Text]
  • Liistro F, Colombo A: Late acute thrombosis after paclitaxel eluting stent implantation. Heart 86: 262-264, 2001.[Abstract/Free Full Text]
  • Walpoth BH, Pavlicek M, Celik B, et al: Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. Eu J Cardiothorac Surg 19: 487-492, 2001.
  • Romero F, Rodriguez-Iturbe B, Pons H, et al: Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit. Atherosclerosis 152: 127-133, 2000.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Farb A, John M, Acampado E, et al: Oral everolimus Inhibits in-stent neointimal growth. Circulation 106: 2379-2379, 2002.[Abstract/Free Full Text]
  • Coussement PK, de Leon H, Ueno T, et al: Intracoro-nary beta-radiation exacerbates long-term neointima formation in balloon-injured pig coronary arteries. Circulation 104: 2459-2464, 2001.[Abstract/Free Full Text]
  • Jeanmart H, Malo O, Carrier M, et al: Comparative study of cyclosporin and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function. J Heart Lung Transplant 21: 990-990, 2002.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kobashigawa JA: Mycophenolate mofetil in cardiac transplantation. Curr Opin Cardiol 13: 117-121, 1998.[ISI][Medline] [Order article via Infotrieve]
  • O’Hair DP, McManus RP, Komorowski R: Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil. Ann Thorac Surg 58: 1311-1315, 1994.[Abstract]
  • Fraser-Smith EB, Rosete JD, Schatzman RC: Suppression by mycophenolate mofetil of the neointimal thickening caused by vascular injury in a rat arterial stenosis model. J Pharmacol Exp Ther 275: 1204-1208, 1995.[Abstract/Free Full Text]
  • Pescovitz MD, Conti D, Dunn J, et al: Intravenous mycophenolate mofetil: Safety, tolerability, and pharmacokinetics. Clin Transplant 14: 179-188, 2000.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Budde K, Glander P, Bauer S, et al: Pharmacodynamic monitoring of mycophenolate mofetil. Clin Chem Lab Med 38: 1213-1216, 2000.[CrossRef][ISI][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilkay, E.
Right arrow Articles by Arslan, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilkay, E.
Right arrow Articles by Arslan, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?